Sex-Specific Effects of Nutritional Supplements for Infants Born Early or Small: An Individual Participant Data

Luling Lin1, Greg D Gamble1, Caroline A Crowther1

  • 1Liggins Institute, University of Auckland, Auckland 1023, New Zealand.

Nutrients
|January 21, 2022
PubMed

Insights

Neonatal nutritional supplements for small infants improved early growth but did not affect childhood BMI. These growth benefits in infancy did not persist into later life and showed no significant sex differences.

Area of Science:

  • Pediatrics
  • Neonatology
  • Nutritional Science

Background:

  • Infants born small require nutritional support for optimal growth.
  • Long-term effects of neonatal nutritional supplements on growth are not well-established.
  • Potential sex-based differences in response to supplementation warrant investigation.

Purpose of the Study:

  • To assess the long-term effects of early macronutrient supplementation on growth in infants born small.
  • To investigate potential sex differences in the response to neonatal nutritional supplements.
  • To evaluate the impact of supplementation on childhood BMI, length, bone mineral content, cognitive impairment, and metabolic risk.

Main Methods:

  • Systematic review and meta-analysis of participant-level data from randomized controlled trials.
  • Included trials focused on preterm or small-for-gestational-age infants receiving macronutrient supplements.
  • Co-primary outcomes included cognitive impairment and metabolic risk; secondary outcomes assessed growth parameters.

Main Results:

  • Supplementation did not alter childhood Body Mass Index (BMI).
  • Infancy length and bone mineral content were increased by supplementation, but these effects did not persist.
  • Subgroup analysis showed increased height z-score in male toddlers, but no significant sex interaction was observed.

Conclusions:

  • Early macronutrient supplementation for small infants does not appear to alter childhood BMI.
  • While infancy growth parameters improved, these benefits were not sustained long-term.
  • The study found no significant sex differences in the overall effects of neonatal nutritional supplementation on growth.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
21.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
Environmental Influences on Intelligence01:29

Environmental Influences on Intelligence

Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children...
486
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
714
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17